Unisyn Technologies, based in San Diego, has introduced Hybrid Grow specialized basal medium for growing hybridomas in the company's Cell-Pharm hollow-fiber bioreactors. The medium elevates glucose and glutamine levels to deliver nutrients to the tissue-dense hollow-fiber hybridoma cultures. According to Unisyn, Hybrid Grow simplifies downstream processing and reduces regulatory concerns because it is free of bovine products. Addition of defined medium supplements to the product increases production rates in serum-free environments, the company says. Hybrid Grow does not contain pherol red, which can interfere with charged-based separation media, such as ion-exchange gels.
Unisyn notes that Hybrid...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!